Cargando…
Recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis
PURPOSE: Evidence of efficacy and safety of, and especially mortality related to, recombinant human thrombomodulin (rhTM) treatment for sepsis-induced disseminated intravascular coagulation (DIC) is limited. We hypothesized that patients with sepsis-induced DIC receiving treatment with rhTM would ha...
Autores principales: | Yamakawa, Kazuma, Ogura, Hiroshi, Fujimi, Satoshi, Morikawa, Miki, Ogawa, Yoshihito, Mohri, Tomoyoshi, Nakamori, Yasushi, Inoue, Yoshiaki, Kuwagata, Yasuyuki, Tanaka, Hiroshi, Hamasaki, Toshimitsu, Shimazu, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607733/ https://www.ncbi.nlm.nih.gov/pubmed/23361628 http://dx.doi.org/10.1007/s00134-013-2822-2 |
Ejemplares similares
-
Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis
por: Yoshimura, Jumpei, et al.
Publicado: (2015) -
Treatment effects of recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study
por: Yamakawa, Kazuma, et al.
Publicado: (2011) -
Impact on survival of whole-body computed tomography before emergency bleeding control in patients with severe blunt trauma
por: Wada, Daiki, et al.
Publicado: (2013) -
A novel technique of differential lung ventilation in the critical care setting
por: Yamakawa, Kazuma, et al.
Publicado: (2011) -
Assessment of risk factors related to healthcare-associated methicillin-resistant Staphylococcus aureus infection at patient admission to an intensive care unit in Japan
por: Yamakawa, Kazuma, et al.
Publicado: (2011)